Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
M.D. Anderson Cancer Center
University of California, Irvine
Peking Union Medical College Hospital
University of Southern California
Brigham and Women's Hospital
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Miami
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
RWTH Aachen University
M.D. Anderson Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Hospital, Brest
M.D. Anderson Cancer Center
University of Birmingham
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Institute of Hematology & Blood Diseases Hospital, China
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute
Fox Chase Cancer Center
University of Utah
University of Nebraska
University Health Network, Toronto
M.D. Anderson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
University of Oklahoma
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
Northwestern University